Alyeska Investment Group
FRLN

Alyeska Investment Group’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Alyeska Investment Group’s Portfolio FRLN Stock Details FRLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,976
Closed -$549K – 887
2021
Q1 		$549K Hold
2,976
– – 0.01% 657
2020
Q4 		$815K Sell
2,976
-24
-0.8% -$6.03K 0.01% 426
2020
Q3 		$702K Buy
+3,000
New +$752K 0.01% 407

Other funds holding FRLN

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Alyeska Investment Group's FRLN Position: Q2 2021 in Review

Alyeska Investment Group sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2021, closing a stake of 2,976 shares — an estimated $549K sold.

Alyeska Investment Group first reported a position in FRLN in Q3 2020 and held it in 3 quarters. The position peaked at $815K in Q4 2020. 16 funds tracked by Wall St. Rank hold FRLN as of Q2 2021.

  • Alyeska Investment Group reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 2,976 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2021, an estimated $549K.
  • Alyeska Investment Group first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 3 quarters.
  • Alyeska Investment Group's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $815K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.